Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
source: pixabay.com

Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment

Albireo has recently initiated their Phase 3 ASSERT trial, according to GlobeNewswire. This study will evaluate odevixibat as a treatment for Alagille syndrome. This therapy fits well with Albireo's mission,…

Continue Reading Initiation of Global Phase 3 Trial of Alagille Syndrome Treatment
Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease
source: pixabay.com

Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease

Researchers have uncovered that there is a link between Alzheimer's disease and three eye conditions- glaucoma, diabetic retinopathy, and macular degeneration (age-related). This could mean that there may be another…

Continue Reading Study Shows Glaucoma and Other Eye Conditions May be Linked to Alzheimer’s Disease